-
NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
(PAR-23-311)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Multiple dates, see announcement.
-
Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial Not Allowed)
(PAR-24-041)
National Institute of General Medical Sciences
Application Receipt Date(s): July 8, 2026
-
NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
(PAR-24-044)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Multiple dates, see announcement.
-
Providing Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and Addiction Scientific Workforce (R25 Clinical Trials Not Allowed)
(PAR-24-048)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): November 13, 2026
-
NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U44-Clinical Trial Required)
(PAR-24-066)
National Eye Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed)
(PAR-24-071)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): September 25, 2026
-
Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional)
(PAR-24-077)
National Institute on Minority Health and Health Disparities
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
National Institute on Drug Abuse
National Institute of Diabetes and Digestive and Kidney Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Center for Complementary and Integrative Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): Multiple dates, see announcement.
-
Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed)
(RFA-AG-25-006)
National Institute on Aging
Application Receipt Date(s): February 14, 2024
-
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
(RFA-CA-24-008)
National Cancer Institute
Application Receipt Date(s): October 1, 2024
-
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
(RFA-CA-24-009)
National Cancer Institute
Application Receipt Date(s): October 1, 2024
-
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
(RFA-CA-24-010)
National Cancer Institute
Application Receipt Date(s): October 1, 2024
-
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
(RFA-CA-24-011)
National Cancer Institute
Application Receipt Date(s): October 1, 2024
-
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
(RFA-CA-24-012)
National Cancer Institute
Application Receipt Date(s): October 1, 2024
-
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
(RFA-CA-24-013)
National Cancer Institute
Application Receipt Date(s): October 1, 2024
-
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
(RFA-CA-24-014)
National Cancer Institute
Application Receipt Date(s): October 1, 2024
-
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P30 Clinical Trial Optional)
(RFA-CA-24-015)
National Cancer Institute
Application Receipt Date(s): October 1, 2024
-
BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (R34 Clinical Trial Optional)
(RFA-DA-24-042)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Deafness and Other Communication Disorders
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): February 15, 2024
-
Cardiovascular Repository Type 1 Diabetes (CARE-T1D) Consortium (U01 Clinical Trial Not Allowed).
(RFA-DK-23-021)
National Institute of Diabetes and Digestive and Kidney Diseases
National Heart, Lung, and Blood Institute
Application Receipt Date(s): April 11, 2024
-
Addressing the Impact of Syndemics on the Health of People with HIV and Diseases and Conditions within the Missions of NIDDK and NHLBI (R01 Clinical Trial Optional)
(RFA-DK-25-001)
National Institute of Diabetes and Digestive and Kidney Diseases
National Heart, Lung, and Blood Institute
Office of Research on Women's Health
Application Receipt Date(s): March 20, 2025
-
Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed
(RFA-FD-24-007)
Food and Drug Administration
Application Receipt Date(s): March 31, 2024
-
Short-Term Research Education Program to Enhance Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)
(RFA-HL-25-001)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): August 19, 2026
-
Early Psychosis Intervention Network (EPINET): Learning Health Care Research to Improve Mental Health Services and Outcomes (P01 Clinical Trial Optional)
(RFA-MH-24-105)
National Institute of Mental Health
Application Receipt Date(s): March 29, 2024
-
Early Psychosis Intervention Network (EPINET) Data Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-MH-24-106)
National Institute of Mental Health
Application Receipt Date(s): March 29, 2024
-
BRAIN Initiative: Marmoset Colonies for Neuroscience Research (U24 Clinical Trials Not Allowed)
(RFA-MH-25-115)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): March 1, 2024
-
BRAIN Initiative: Marmoset Coordination Center (U24 Clinical Trials Not Allowed)
(RFA-MH-25-116)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): March 1, 2024
-
Short Courses to Promote the Broad and Rigorous Use of Common Fund Data (R25 Clinical Trial Not Allowed)
(RFA-RM-23-014)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): February 14, 2024
-
Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required)
(RFA-TR-24-001)
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
Application Receipt Date(s): March 15, 2024